close
Fox News Flash top headlines are here. Check out what’s clicking on Foxnews.com.
The European Commission has authorized GSK’s HIV-focused unit ViiV Healthcare’s cabotegravir long-acting injectable and tablets, the British drugmaker said on Tuesday.
EUROPEAN COMMISSION CHIEF URSULA VON DER LEYEN ASSURES AID TO FLOOD-STRICKEN SLOVENIA DURING VISIT
Cabotegravir is recommended in combination with safer sex practices for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually-acquired HIV-1 infection in high-risk adults and adolescents weighing at least 77.16 pounds, according to the company.
The GlaxoSmithKline logo is seen in this illustration, Aug. 10, 2022. (REUTERS/Dado Ruvic/Illustration/File Photo)
Sold under brand name Apretude, it is currently approved for use in the United States, Australia, Zimbabwe, South Africa, Malawi, Botswana and Brazil.
CLICK HERE TO GET THE FOX NEWS APP
President Donald Trump is fresh off his 100th day in office and says his administration…
Rep. Marjorie Taylor Greene, R-Ga., expressed her frustrations on a variety of political topics on…
Bloated bureaucracy and growing debt are holding back President Donald Trump’s economic "golden age," according…
close Video Mauro weighs in on New England serial killer theory Fox News contributor and…
close Video Grieving father shares story of his son's fatal drug overdose Steve Muth speaks…
BOSTON, Mass. – Former Vice President Mike Pence was honored on Sunday night for his…